Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database

McGuigan, 2018, Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes, World J Gastroenterol, 24, 4846, 10.3748/wjg.v24.i43.4846 2019, American Cancer Society. Facts & Figures 2019, Am Cancer Soc Oh, 2015, Rare long-term survivors of pancreatic adenocarcinoma without curative resection, World J Gastroenterol, 21, 13574, 10.3748/wjg.v21.i48.13574 Tempero, 2019, Pancreatic adenocarcinoma, version 1.2019 featured updates to the NCCN guidelines, JNCCN J Natl Compr Cancer Netw, 17 Burris, 1997, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial, J Clin Oncol, 15, 2403, 10.1200/JCO.1997.15.6.2403 Conroy, 2011, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, 364, 1817, 10.1056/NEJMoa1011923 Von Hoff, 2013, Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine, N Engl J Med, 369, 1691, 10.1056/NEJMoa1304369 Hackert, 2016, Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients, Ann Surg, 264, 457, 10.1097/SLA.0000000000001850 2019 Pagani, 2010, International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?, J Natl Cancer Inst, 102, 456, 10.1093/jnci/djq029 Shrikhande, 2007, Pancreatic resection for M1 pancreatic ductal adenocarcinoma, Ann Surg Oncol, 14, 118, 10.1245/s10434-006-9131-8 Yang, 2020, Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection, HPB, 22, 91, 10.1016/j.hpb.2019.05.015 Crippa, 2016, Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?, Eur J Surg Oncol, 42, 1533, 10.1016/j.ejso.2016.06.398 Tachezy, 2016, Synchronous resections of hepatic oligometastatic pancreatic cancer: disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis, Surgery, 160, 136, 10.1016/j.surg.2016.02.019 Kandel, 2018, Survival of patients with oligometastatic pancreatic ductal adenocarcinoma treated with combined modality treatment including surgical resection: a pilot study, J Pancreat Cancer, 4, 88 Hackert, 2017, Radical surgery of oligometastatic pancreatic cancer, Eur J Surg Oncol, 43, 358, 10.1016/j.ejso.2016.10.023 Haj Mohammad, 2016, Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands, J Cancer Res Clin Oncol, 142, 1353, 10.1007/s00432-016-2140-5 Kim, 2016, Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma, HPB, 18, 325, 10.1016/j.hpb.2015.10.014 Klein, 2012, The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma, Gastroenterol Res Pract, 2012, 10.1155/2012/939350 Takada, 1997, Simultaneous hepatic resection with pancreato-duodenectomy for metastatic pancreatic head carcinoma: does it improve survival?, Hepatogastroenterology, 44, 567 Gleisner, 2007, Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?, Cancer Interdiscip, 110, 2484 Zanini, 2015, Surgery for isolated liver metastases from pancreatic cancer, Updates Surg, 67, 19, 10.1007/s13304-015-0283-6 Gu, 2020, Surgical resection of metastatic pancreatic cancer: is it worth it? A 15-year experience at a single Chinese center, J Gastrointest Oncol, 11, 319, 10.21037/jgo.2020.03.02 Inal, 2012, Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an anatolian society of medical oncology multicenter study, Asian Pacific J Cancer Prev, 13, 1841, 10.7314/APJCP.2012.13.5.1841 Wright, 2016, Primary tumor resection following favorable response to systemic chemotherapy in stage IV pancreatic adenocarcinoma with synchronous metastases: a bi-institutional analysis, J Gastrointest Surg, 20, 1830, 10.1007/s11605-016-3256-2 Tanaka, 2019, CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX, Eur J Surg Oncol, 45, 1453, 10.1016/j.ejso.2019.03.039 Kopetz, 2009, Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy, J Clin Oncol, 27, 3677, 10.1200/JCO.2008.20.5278 Mayo, 2010, Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis, Ann Surg Oncol, 17, 3129, 10.1245/s10434-010-1154-5 Ejaz, 2018, Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis, HPB, 20, 277, 10.1016/j.hpb.2017.08.039 Addeo, 2014, Safety and outcome of combined liver and pancreatic resections, Br J Surg, 101, 693, 10.1002/bjs.9443 De Simoni, 2020, Oligometastatic pancreatic cancer to the liver in the era of neoadjuvant chemotherapy: which role for conversion surgery? A systematic review and meta-analysis, Cancers (Basel), 12, 3402, 10.3390/cancers12113402